SCAHT groups join Horizon 2020 project on nanosafety
NanoREG II is a large EU Horizon 2020 project concerned with the development and implementation of grouping and Safe-by-Design approaches within regulatory frameworks. Earlier in the year SCAHT was invited to join this project which started in September 2015 and will run over 3 years. The research groups of Prof Luc Stoppini, HEPIA Geneva, and Prof Jörg Huwyler as well as the SCAHT Regulatory Toxicology group, both at the University of Basel, have joined the consortium which has now 42 members from across Europe. The SCAHT contribution will focus on transport of nanoparticles across the blood-brain barrier, characterisation and toxicity assessment of nanoparticles in vitro and in vivo, and contributing to studying current regulatory frameworks for nanoparticles in pharmaceuticals and medical devices. Further information.
SCAHT-Forschungsgruppenleiter, Prof. Luigi Terracciano, erhält angesehenen Preis
Die Dr. med. Dora Seif-Stiftung mit Sitz in Basel vergibt alle zwei Jahre den mit 5000 Franken dotierten Dora-Seif-Krebsforschungspreis für «die beste Arbeit, die zur Verbesserung der Frühdiagnostik und Therapie (Vorbeugung und Verhütung) des Krebses beiträgt». Die Stiftung verleiht den diesjährigen Preis zu gleichen Teilen an Prof. Markus Heim, Chefarzt Gastroenterologie & Hepatologie am Universitätsspital Basel und Forschungsgruppenleiter am Departement Biomedizin der Universität Basel, und an Prof. Luigi Terracciano, Fachbereichsleiter Molekularpathologie und Forschungsgruppenleiter am Institut für Pathologie des Universitätsspitals Basel. Link zu vollständigem Artikel.
Toxics 2017 Travel Award - Apply by 30 November 2016
CHF 800 award supporting travel for postdoctoral fellow or non-fellow postdoctoral trainee to present his/her research, in poster or oral presentation formats, at a scientific conference in 2017. Currently, applications for this award are accepted. Please send applications to firstname.lastname@example.org by 30 November, 2016. The requirements for candidate participation and application details are described here.
EUROTOX is deeply concerned about the current situation of academic toxicology in Europe
EUROTOX is deeply concerned about the current situation in academia and how it will impact on the future of Toxicology in Europe. Departments of Toxicology in universities are shrinking or disappearing. Toxicology as an academic discipline is essential to protect the health of consumers, workers and the environment. Strengthening toxicology in academic institutions is a basic requirement for scientific innovation and for the education and development of young scientists. The Executive Committee of EUROTOX has recently published a position paper highlighting the challenging issues facing academic toxicology in Europe. See further information.
Next MAS in Toxicology programme starts in September 2016
31 August 2016 is the application deadline for the Master of Advanced Studies (MAS) in Toxicology programme, starting September 2016. The programme is run by the School of Pharmaceutical Sciences at the University of Geneva and the University of Lausanne in collaboration with the SCAHT. It is a two year part-time study programme consisting of four day teaching blocks every three weeks over three semesters and requires students to write a Master’s thesis. Successful completion of the course is recognised as providing the theoretical knowledge for professional registration as a toxicologist by EUROTOX. There is a possibility to attend individual modules with free-student status if places are available. For prerequisites and further information click here.
EU critera for Endocrine Disrupting Chemicals
On 15 June, after a delay of more than 2 years, the European Commission presented draft scientific criteria to identify endocrine disruptors under pesticides and biocides legislation. Identification requires establishing a causal link between adverse effects on human health and an endocrine mode of action; health effects and mode of action should consider all relevant scientific evidence by robust systematic review, using a weight of evidence-based approach. See EU press release.
EFSA Traineeships Call 2016
European Food Safety Authority: Are you a young graduate searching for a challenging experience in a stimulating and dynamic EU Agency? Do you want to apply your skills and knowledge in one of the areas within EFSA’s remit? Are you searching for an opportunity to be involved in a European organisation’s daily work? Apply for a traineeship by 31 July 2016. As a trainee you will provide contribution to the general activities of EFSA, under the supervision of a Traineeship Adviser through a rewarding and challenging experience in a multicultural environment. Further information.
Dr. Martial Saugy appointed as Director of new Center of Research and Expertise in anti-Doping sciences
Dr. Martial Saugy, former Head of the Swiss Laboratory for Doping Analyses (LAD), has been appointed as the new and first Director of the just founded REDs - Center of Research and Expertise in anti-Doping sciences located on the grounds of the University of Lausanne. The new center was inaugurated on 25 May 2016 and will provide independent expertise and research in anti-doping sciences in a multidisciplinary and innovative approach, as well as reinforce education at academic level and training to all stakeholders involved with doping in the wider scientific, medical and sport community. Link to report in RTS Journal, 25.05.2016, 19:30h about the REDs.
EUROTOX 2016 Congress - Final call for abstracts
20th European Congress on Alternatives to Animal Testing / 17th Annual Congress of EUSAAT, Linz (AT)
Registration is open for the 20th European Congress on Alternatives to Animal Testing / 17th Annual Congress of EUSAAT which will take place in Linz, Austria, on 24 - 27 August 2016. This includes a Practical Training Course "Application of commercially available human tissue models". EUSAAT Young Scientist Travel Awards are available. Deadline for travel award and abstract submission is 31 May 2016. Further information.